ATE414763T1 - Humane kinase pak65 - Google Patents

Humane kinase pak65

Info

Publication number
ATE414763T1
ATE414763T1 AT96903482T AT96903482T ATE414763T1 AT E414763 T1 ATE414763 T1 AT E414763T1 AT 96903482 T AT96903482 T AT 96903482T AT 96903482 T AT96903482 T AT 96903482T AT E414763 T1 ATE414763 T1 AT E414763T1
Authority
AT
Austria
Prior art keywords
hpak65
protein
activity
modulate
methods
Prior art date
Application number
AT96903482T
Other languages
English (en)
Inventor
Arie Abo
George Martin
Original Assignee
Onyx Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Onyx Pharma Inc filed Critical Onyx Pharma Inc
Application granted granted Critical
Publication of ATE414763T1 publication Critical patent/ATE414763T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
AT96903482T 1995-01-06 1996-01-05 Humane kinase pak65 ATE414763T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/369,780 US5518911A (en) 1995-01-06 1995-01-06 Human PAK65

Publications (1)

Publication Number Publication Date
ATE414763T1 true ATE414763T1 (de) 2008-12-15

Family

ID=23456883

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96903482T ATE414763T1 (de) 1995-01-06 1996-01-05 Humane kinase pak65

Country Status (11)

Country Link
US (5) US5518911A (de)
EP (1) EP0802921B1 (de)
JP (2) JPH10512143A (de)
AT (1) ATE414763T1 (de)
AU (1) AU702308B2 (de)
CA (1) CA2209426C (de)
DE (1) DE69637754D1 (de)
DK (1) DK0802921T3 (de)
ES (1) ES2319583T3 (de)
PT (1) PT802921E (de)
WO (1) WO1996020948A1 (de)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5518911A (en) * 1995-01-06 1996-05-21 Onyx Pharmaceuticals, Inc. Human PAK65
US5863532A (en) * 1996-03-14 1999-01-26 The Regents Of The University Of California Compositions and methods comprising cytostatic protein kinase
NZ334613A (en) * 1996-08-12 2002-02-01 Welfide Corp Pharmaceutical agents comprising Rho kinase inhibitor
WO1998007830A2 (en) 1996-08-22 1998-02-26 The Institute For Genomic Research COMPLETE GENOME SEQUENCE OF THE METHANOGENIC ARCHAEON, $i(METHANOCOCCUS JANNASCHII)
US6777176B1 (en) * 1997-02-19 2004-08-17 Arpida Ag Target system
ATE280778T1 (de) * 1997-02-19 2004-11-15 Arpida Ag Verfahren zur behandlung von mikrobiellen infektionen mittles entkupplung des phosphotransferase-systems und dazu geeingnete wirkstoffe
US6069229A (en) * 1997-03-07 2000-05-30 Schering Corporation Mammalian proteinases; oxidoreductases; related reagents
EP0983359A1 (de) * 1997-06-11 2000-03-08 Chiron Corporation Erkennung des hubub1 wildtygenverlusts
US6410312B1 (en) 1997-12-19 2002-06-25 Chiron Corporation huBUB3 gene involved in human cancers
US6227658B1 (en) 1997-06-23 2001-05-08 Kabushiki Kaisha Toshiba Apparatus and method for forming thin film using ink-jet mechanism
EP0889127A1 (de) * 1997-07-01 1999-01-07 Smithkline Beecham Corporation Serine/Threonine Protein Kinase (H-SGK2)
US6218109B1 (en) * 1997-09-05 2001-04-17 Baylor College Of Medicine Mammalian checkpoint genes and proteins
US6524833B1 (en) 1997-12-09 2003-02-25 Children's Medical Center Corporation Two sterile-20 kinase-like proteins and methods of use thereof
JPH11232291A (ja) * 1998-02-16 1999-08-27 Seibutsu Bunshi Kogaku Kenkyusho:Kk 蛋白質立体構造データベース検索方法
US6013500A (en) 1998-05-21 2000-01-11 The Trustees Of Columbia University In The City Of New York PAK4, a novel gene encoding a serine/threonine kinase
AU770667B2 (en) 1998-08-07 2004-02-26 Onyx Pharmaceuticals, Inc. CHP polypeptide, a ligand of PAK65
US6383734B1 (en) 1998-09-30 2002-05-07 Advanced Research And Technology Institute, Inc. Method to determine inhibition of PAK3 activation of Raf-1
US6013455A (en) * 1998-10-15 2000-01-11 Incyte Pharmaceuticals, Inc. Protein kinase homologs
EP1088898A1 (de) * 1999-09-16 2001-04-04 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Assay zur Detektierung von Substanzen für die Krebstherapie und infektiöser Krankheiten
CN1315568A (zh) * 2000-03-28 2001-10-03 上海博德基因开发有限公司 一种新的多肽——人atp依赖的丝氨酸蛋白水解酶11.4和编码这种多肽的多核苷酸
CN1315567A (zh) * 2000-03-28 2001-10-03 上海博德基因开发有限公司 一种新的多肽——人atp依赖的丝氨酸蛋白水解酶10和编码这种多肽的多核苷酸
CN1315566A (zh) * 2000-03-28 2001-10-03 上海博德基因开发有限公司 一种新的多肽——人atp依赖的丝氨酸蛋白水解酶52和编码这种多肽的多核苷酸
CN1315571A (zh) * 2000-03-29 2001-10-03 上海博德基因开发有限公司 一种新的多肽——人atp依赖的丝氨酸蛋白水解酶9.8和编码这种多肽的多核苷酸
CN1315573A (zh) * 2000-03-29 2001-10-03 上海博德基因开发有限公司 一种新的多肽——人atp依赖的丝氨酸蛋白水解酶11和编码这种多肽的多核苷酸
CN1315570A (zh) * 2000-03-29 2001-10-03 上海博德基因开发有限公司 一种新的多肽——人atp依赖的丝氨酸蛋白水解酶16和编码这种多肽的多核苷酸
CN1315572A (zh) * 2000-03-29 2001-10-03 上海博德基因开发有限公司 一种新的多肽——人atp依赖的丝氨酸蛋白水解酶12和编码这种多肽的多核苷酸
CN1315569A (zh) * 2000-03-29 2001-10-03 上海博德基因开发有限公司 一种新的多肽——人atp依赖的丝氨酸蛋白水解酶11.3和编码这种多肽的多核苷酸
CN1321768A (zh) * 2000-04-29 2001-11-14 上海博德基因开发有限公司 一种新的多肽——人atp依赖的丝氨酸蛋白水解酶21和编码这种多肽的多核苷酸
CN1322834A (zh) * 2000-05-09 2001-11-21 上海博德基因开发有限公司 一种新的多肽——人atp依赖的丝氨酸蛋白水解酶9.2和编码这种多肽的多核苷酸
CA2413156C (en) * 2000-07-03 2009-08-18 Gala Design, Inc. Expression vectors
AU2001271614B2 (en) 2000-07-03 2007-05-31 Catalent Pharma Solutions, Llc Host cells containing multiple integrating vectors
FR2812945B1 (fr) * 2000-08-10 2002-10-04 Aventis Pharma Sa Utilisation de la proteine grf1 et cellules exprimant la proteine grf1 pour le criblage de molecules
EP1233060B1 (de) * 2001-02-14 2007-11-14 Sysmex Corporation Verfahren zur Bestimmung der Aktivität des Zellzyklus-Regulationsfaktors und Verfahren zur Diagnose von Krebs unter Verwendung desselben
US20030134353A1 (en) * 2001-03-08 2003-07-17 Bioteknologisk Institut Recombinant dimorphic fungal cell
WO2003006614A2 (en) * 2001-07-12 2003-01-23 Exelixis, Inc. UBE2s AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE
US7514207B2 (en) * 2001-08-13 2009-04-07 Massachusetts Institute Of Technology Methods of screening for compounds that decrease phosphorylation of merlin and may be useful in cancer treatment
CA2472118A1 (en) 2001-12-28 2003-07-17 The Trustees Of Columbia University In The City Of New York Pak5-related compositions and methods
JP3960083B2 (ja) * 2002-03-06 2007-08-15 セイコーエプソン株式会社 ヘッド駆動装置及び方法、液滴吐出装置、ヘッド駆動プログラム、並びにデバイス製造方法及びデバイス
US20040038304A1 (en) * 2002-03-28 2004-02-26 Gala Design, Inc. Antibody libraries
US7384738B2 (en) * 2002-03-28 2008-06-10 Bremel Robert D Retrovirus-based genomic screening
US20040009935A1 (en) * 2002-07-03 2004-01-15 Isis Pharmaceuticals Inc. Antisense modulation of p21-activated kinase 2 expression
WO2004014947A1 (en) * 2002-08-06 2004-02-19 Aventis Pharma Deutschland Gmbh Method for isolating an intestinal cholesterol binding protein
US20040248323A1 (en) * 2003-06-09 2004-12-09 Protometrix, Inc. Methods for conducting assays for enzyme activity on protein microarrays
US7364887B2 (en) * 2003-07-18 2008-04-29 Sanofi-Aventis Deutschland Gmbh Use of PAK inhibitor for the treatment of a joint disease
EP1498133A1 (de) * 2003-07-18 2005-01-19 Aventis Pharma Deutschland GmbH Verwendung von pak-Inhibitoren zur Behandlung von Gelenkerkrankungen
US20050221429A1 (en) * 2004-01-16 2005-10-06 Cardinal Health Pts, Llc Host cells containing multiple integrating vectors comprising an amplifiable marker
WO2005094876A1 (en) * 2004-03-04 2005-10-13 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with p21 (cdkn1a)-activated kinase 2 (pak2)
US20090111786A1 (en) * 2004-12-03 2009-04-30 Glass Christopher K Compounds that Prevent Macrophage Apoptosis and Uses Thereof
WO2009051825A1 (en) * 2007-10-17 2009-04-23 University Of Miami Use of rac1 inhibitors to treat kaposi's sarcoma
US7998688B2 (en) * 2008-03-07 2011-08-16 OSI Pharmaceuticals, LLC Inhibition of EMT induction in tumor cells by anti-cancer agents

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5518911A (en) * 1995-01-06 1996-05-21 Onyx Pharmaceuticals, Inc. Human PAK65
US5863532A (en) * 1996-03-14 1999-01-26 The Regents Of The University Of California Compositions and methods comprising cytostatic protein kinase

Also Published As

Publication number Publication date
JP2006230410A (ja) 2006-09-07
PT802921E (pt) 2009-02-25
EP0802921B1 (de) 2008-11-19
US5605825A (en) 1997-02-25
AU4756096A (en) 1996-07-24
DK0802921T3 (da) 2009-03-16
US5698445A (en) 1997-12-16
ES2319583T3 (es) 2009-05-08
WO1996020948A1 (en) 1996-07-11
EP0802921A1 (de) 1997-10-29
AU702308B2 (en) 1999-02-18
US5698428A (en) 1997-12-16
CA2209426C (en) 2008-10-07
EP0802921A4 (de) 2000-03-29
US5518911A (en) 1996-05-21
CA2209426A1 (en) 1996-07-11
DE69637754D1 (de) 2009-01-02
JPH10512143A (ja) 1998-11-24
US6013464A (en) 2000-01-11

Similar Documents

Publication Publication Date Title
DE69637754D1 (de) Humane kinase pak65
FI906267A0 (fi) Kontrollinstrument foer periferiartaerer.
DE69005385D1 (de) Kontrollvorrichtung zum richtigen Anbringen von medizinischen Instrumenten.
DE68920684D1 (de) System zur Diskrimination von Signalen.
DE68915006D1 (de) System zum Generieren von Musterdaten.
DE58908974D1 (de) Datengesteuerter Arrayprozessor.
DE69018117D1 (de) Zur Synthese von Karotinoiden verwendbare DNA-Sequenzen.
DE3785409D1 (de) Vorrichtung zur untersuchung von ortsveraenderlichen medien mittels ultraschall-echographie.
SE7811315L (sv) Proteininnehallande fodoemne
FR2591116B1 (fr) Appareil de traitement par hyperthermie.
DE3141647A1 (de) Chirugisches instrument zum anlegen von klammern
DE3685344D1 (de) Vorrichtung zur feststellung von okkultem blut.
FI892408L (fi) Fibronektinbindande protein.
IT8919535A0 (it) Alimento solido che contiene dunalielia algae e procedimento per la sua produzione.
FI895627A0 (fi) Foerlaengda nukleotidsekvenser.
DE3765138D1 (de) Mehrschichtiges element zur quantitativen analyse von immunoreagenzien.
ATA565078A (de) Scheibenmuehle zur aufbereitung von faser- haltigen stoffen
EP0218696A4 (de) Menschliches antientzündungs-phospholipase-inhibitorprotein.
DE3884084D1 (de) Vorrichtung zum Filetieren von Fischen.
DE68920418D1 (de) System zur Evozierung von elektroencephalographischen Signalen.
DE3852675D1 (de) Steuerungssystem zum Lesen von Mikrocode.
DK71986A (da) Polypeptider fra rhinovirusstamme hrv2 samt de herfor kodende dna-molekyler, fremgangsmaade til polypeptidernes fremstilling og deres anvendelse
DE69019082D1 (de) Viskositätsabhängiges System zur Durchflussteuerung.
FR2616454B1 (fr) Appareil de tressage
ATE116368T1 (de) Vektoren und verbindungen zur expression von zymogen-formen von menschlichem protein c.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0802921

Country of ref document: EP